Entities / Company
Immunome (United States).
company in Philadelphia, United States
- Reports this week
- 1
- Active events
- 1
- Connections
- 31
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
Gone quiet
No new reports in 90+ days-
Zacks provided stock analysis and rankings for Immunome, a company operating in the medical/biomedical industry.Speculative1 report
-
Immunome management announced plans to present at a conference on September 3, 2025.Some support2 reports
-
Immunome adheres to Nasdaq Listing Rule 5635(c)(4).Some support3 reports
No events began in the chosen period. Widen it, or reset.
History
Events by the month they beganJune 2026
4 events- Immunome is developing targeted cancer therapies; on August 7, 2025, the EMA granted Orphan Drug Designation to varegacestat, and the FDA also granted the designation.
- Zacks provided stock analysis and rankings for Immunome, a company operating in the medical/biomedical industry.
- Immunome management announced plans to present at a conference on September 3, 2025.
- Immunome adheres to Nasdaq Listing Rule 5635(c)(4).